Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$57.56 - $82.54 $172,392 - $247,207
-2,995 Closed
0 $0
Q4 2021

Feb 01, 2022

SELL
$72.5 - $100.68 $76,125 - $105,714
-1,050 Reduced 25.96%
2,995 $233,000
Q2 2021

Aug 17, 2021

BUY
$93.66 - $139.27 $9,366 - $13,927
100 Added 2.53%
4,045 $503,000
Q1 2021

May 06, 2021

BUY
$116.57 - $155.01 $25,528 - $33,947
219 Added 5.88%
3,945 $520,000
Q4 2020

Jan 28, 2021

BUY
$99.61 - $142.12 $87,258 - $124,497
876 Added 30.74%
3,726 $494,000
Q3 2020

Nov 10, 2020

BUY
$72.92 - $102.01 $207,822 - $290,728
2,850 New
2,850 $291,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Occidental Asset Management, LLC Portfolio

Follow Occidental Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Occidental Asset Management, LLC with notifications on news.